HERNDON, Va., July 18, 2018 /PRNewswire/ -- ExL Events is proud to announce the Collaborations Addressing Vulnerable Populations (CAVP) Forum,taking place on October 16–17 at the Hilton Washington Dulles Airport in Herndon, VA.
There is a need to address the social and economic burdens inflicted by neglected tropical and rare diseases due
With four distinct tracks, the CAVP Forum is designed to provide a holistic view of the challenges facing life science organizations developing treatments for underserved patient populations with unmet medical needs. Click here to register. Use Discount Code C1069PRNEWS to save 15% off the standard rate.
Participants can tailor their educational experience by attending sessions from any of the following tracks:
Priority Review Voucher (PRV) track:
The only event to understand the benefits and challenges of developing a drug that would be eligible for a PRV.
Strategic Partnerships for Drug Repurposing track: Designed for drug development professionals who build the strategies, models, and platforms to discover novel indications for previously established drugs.
Neglected Tropical Diseases (NTD) track: Explore the hurdles of multi-sector partnerships, and the impact these partnerships have on regulatory/access strategies and global health programs that encourages capacity building in the developing world.
Pioneering Investment and Business Models for Drug Development track: Provides a platform for traditional and alternative investors to discuss innovative deal structures and investment models that can de-risk collaborations and partnerships, and help assist the development of drugs for unmet medical needs.
View this year's highly anticipated agenda!
ExL Events is also excited to announce our partnership with Cures Within Reach. Participants of the CAVP Forum will have the opportunity to attend CureAccelerator Live!, a philanthropic pitch competition, rooted in drug repurposing innovation. The finalists of this competition will be Principal Investigators from the Mid-Atlantic region's research institutions and will be announced in September 2018.
The winner will receive funding for the next breakthrough repurposing treatment.
Click here to register. Use Discount Code C1069PRNEWS to save 15% off the standard rate.
For more information, please contact Zohaib Sheikh, Senior Conference Director, at email@example.com.
View original content:http://www.prnewswire.com/news-releases/exl-events-launches-a-drug-repurposing-ntd-priority-review-voucher-and-investment-focused-event-300682492.html
SOURCE ExL Events
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All